Although epidemiological and mechanistic studies have implicated ALPK1 in gout, chronic kidney disease, and diabetes, no study has reported whether ALPK1 is directly involved in these inflammatory diseases that contribute to cancer risk. This evidence concerns the gene ALPK1 and chronic kidney disease.